Stocks › EHC
Encompass Health Corp
EHC·NYSE·
United States·USD
$133.65
+1.37 (+1.04%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
EHC
Encompass Health Corp · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EHCS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of EHC by members of U.S. Congress · 13 on record · 3 in the last 12 months
Whale Activity
Position changes in EHC reported for 2026-09-30 by 680 institutional filers
- Increased221
- New81
- Held98
- Decreased192
- Closed48
- No prior filing40
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 10.5M | $1.27B | decreased |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.5M | $668.0M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.9M | $595.0M | decreased |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4M | $536.8M | decreased |
| STATE STREET CORP | 3.2M | $387.7M | increased |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.7M | $330.6M | increased |
| CITADEL ADVISORS LLC | 2.6M | $310.4M | decreased |
| DIMENSIONAL FUND ADVISORS LP | 1.9M | $233.6M | increased |
| ALLIANCEBERNSTEIN L.P. | 1.9M | $229.8M | decreased |
| WELLINGTON MANAGEMENT GROUP LLP | 1.9M | $228.5M | decreased |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $224.4M | decreased |
| MILLENNIUM MANAGEMENT LLC | 1.6M | $192.8M | increased |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by EHC insiders, by quarter · Form 4
Recent Insider Transactions
1,029 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Price Andrew LChief Accounting Officer | Sale | −5,211 | $120.93 | $630K | Aug 31, 2026 | Form 4 ↗ |
| Darby John PatrickEVP, Gen Counsel & Secretary | Sale | −4,858 | $121.09 | $588K | Aug 31, 2026 | Form 4 ↗ |
| Darby John PatrickEVP, Gen Counsel & Secretary | Option exercise | +4,858 | $35.06 | $170K | Aug 31, 2026 | Form 4 ↗ |
| COLTHARP DOUGLAS EEVP & Chief Financial Officer | Sale | −18.9K | $125.38 | $2.4M | Aug 10, 2026 | Form 4 ↗ |
| Tarr Mark JPresident & CEO · Director | Sale | −1,579 | $126.06 | $199K | Aug 10, 2026 | Form 4 ↗ |
| Tarr Mark JPresident & CEO · Director | Sale | −171.6K | $125.46 | $21.5M | Aug 10, 2026 | Form 4 ↗ |
| Darby John PatrickEVP, Gen Counsel & Secretary | Sale | −8,906 | $125.95 | $1.1M | Aug 10, 2026 | Form 4 ↗ |
| Reidy Christopher RDirector | Grant / award | +319 | $112.40 | $36K | Jul 16, 2026 | Form 4 ↗ |
| Christie Edward M IIIDirector | Grant / award | +248 | $112.43 | $28K | Jul 16, 2026 | Form 4 ↗ |
| Reidy Christopher RDirector | Grant / award | +21 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| Christie Edward M IIIDirector | Grant / award | +11 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| Williams TerranceDirector | Grant / award | +29 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| SCHLICHTING NANCY MDirector | Grant / award | +40 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| O'Connor Kevin J.Director | Grant / award | +19 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| KATZ LESLYE GDirector | Grant / award | +85 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| HERMAN JOAN EDirector | Grant / award | +85 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| Hayes Cain ADirector | Grant / award | +4 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| CARMICHAEL GREG DDirector | Grant / award | +29 | $0.00 | $0 | Jul 15, 2026 | Form 4 ↗ |
| COLTHARP DOUGLAS EEVP & Chief Financial Officer | Sale | −1 | $107.28 | $107 | May 15, 2026 | Form 4 ↗ |
| COLTHARP DOUGLAS EEVP & Chief Financial Officer | Sale | −27.7K | $106.83 | $3.0M | May 15, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding EHC · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF iShares Trust | 3.4M | $343.2M | 0.28% | Jun 30, 2026 |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.2M | $318.5M | 0.01% | Jun 30, 2026 |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust | 2.3M | $237.3M | 1.87% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2.3M | $230.0M | 0.12% | Jun 30, 2026 |
| VANGUARD SMALL-CAP VALUE INDEX FUND VANGUARD INDEX FUNDS | 1.4M | $145.7M | 0.21% | Jun 30, 2026 |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1.3M | $139.1M | 0.36% | Jul 31, 2026 |
| T. Rowe Price U.S. Large-Cap Core Fund, Inc. | 1.2M | $117.3M | 0.65% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1.1M | $115.0M | 0.12% | Jun 30, 2026 |
| VANGUARD EXPLORER FUND | 1.0M | $115.0M | 0.52% | Jul 31, 2026 |
| SMALLCAP World Fund Inc | 848.0K | $85.7M | 0.09% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list EHC's shares (CUSIP 29261A100), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming encompass health as client
- POWERS PYLES SUTTER & VERVILLE, P.C.ENCOMPASS HEALTH CORPORATION · 2026 Q3 · HCR$10K
Filing ↗ - SCULLY ROSKEY AND MISSMARENCOMPASS HEALTH · 2026 Q3 · MMM$110K
Filing ↗ - ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION) · 2026 Q3 · HCR, MMM$230K
Filing ↗ - RS GROUP CONSULTING LLCENCOMPASS HEALTH · 2026 Q3 · HCR$20K
Filing ↗ - ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION)ENCOMPASS HEALTH CORPORATION (FKA HEALTHSOUTH CORPORATION) · 2026 Q2 · MMM, HCR$270K
Filing ↗
Government Contracts
Federal awards to Encompass Health Corp · USAspending
No federal contract awards found for Encompass Health Corp.
U.S. Patents
Recent USPTO applications naming Encompass Health Corp
No USPTO patent applications found for Encompass Health Corp.
Annual Financials
From EHC's 10-K filings · XBRL
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.37B | $4.80B | $4.35B | $4.01B |
| Operating income | n/a | n/a | n/a | $539.5M | $559.6M |
| Net income | $566.2M | $455.7M | $352.0M | $271.0M | $412.2M |
| Diluted EPS | $5.54 | $4.46 | $3.47 | $2.70 | $4.11 |
| Operating cash flow | n/a | n/a | n/a | $705.8M | $715.8M |
| Cash and equivalents | $72.2M | $85.4M | $69.1M | $21.8M | $49.4M |
| Total assets | $7.09B | $6.53B | $6.10B | $5.64B | $6.86B |
| Total liabilities | $3.81B | $3.69B | $3.81B | $3.77B | $4.47B |
| Shareholders' equity | $2.44B | $2.07B | $1.65B | $1.31B | $1.91B |
As Encompass Health Corp tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 26, 2026 ↗
Stock Splits
Every split and reverse split in the price history
No stock splits in EHC's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 7.01, 9.01Reg FD disclosureNov 6, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureOct 28, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsAug 13, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureAug 5, 2026
EDGAR ↗ - 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationJun 1, 2026
EDGAR ↗ - 8-K · Items 1.01, 8.01, 9.01Material agreement · Other eventsMay 15, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 11, 2026
EDGAR ↗
About Encompass Health Corp
From SEC EDGAR company records
Industry (SIC 8060)Services-Hospitals
SectorHealthcare
HeadquartersBIRMINGHAM, AL
IncorporatedDE
SEC CIK0000785161 ↗
Former namesHEALTHSOUTH CORP, HEALTHSOUTH REHABILITATION CORP




